Integra LifeSciences Reports Third Quarter 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Integra LifeSciences (IART) Misses Q3 EPS by 2c; Lowers Outlook
October 26, 2017 6:10 AM EDTIntegra LifeSciences (NASDAQ: IART) reported Q3 EPS of $0.45, $0.02 worse than the analyst estimate of $0.47. Revenue for the quarter came in at $278.8 million versus the consensus estimate of $286.33 million.
GUIDANCE:
Integra LifeSciences sees FY2017 EPS of $1.83-$1.87, versus the consensus of... More
